The relationship between the Hopkins symptom checklist-10 and diagnoses of anxiety and depression among inpatients with substance use disorders

References

• Andersson HW, Mosti MP, Nordfjaern T. Inpatients in substance use treatment with co-occurring psychiatric disorders: a prospective cohort study of characteristics and relapse predictors. BMC Psychiatry,. 2023;23(1):152. doi: 10.1186/s12888-023-04632-z.
   PubMed Web of Science ®Google Scholar
• Bergman BG, Greene MC, Slaymaker V, et al. Young adults with co-occurring disorders: substance use disorder treatment response and outcomes. J Subst Abuse Treat. 2014;46(4):420–428. doi: 10.1016/j.jsat.2013.11.005.
   PubMed Web of Science ®Google Scholar
• Chen KW, Banducci AN, Guller L, et al. An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program. Drug Alcohol Depend. 2011;118(2–3):92–99. doi: 10.1016/j.drugalcdep.2011.03.003.
   PubMed Web of Science ®Google Scholar
• Mortlock KS, Deane FP, Crowe TP. Screening for mental disorder comorbidity in Australian alcohol and other drug residential treatment settings. J Subst Abuse Treat. 2011;40(4):397–404. doi: 10.1016/j.jsat.2011.01.002.
   PubMed Web of Science ®Google Scholar
• Gielen N, Havermans R, Tekelenburg M, et al. Prevalence of post-traumatic stress disorder among patients with substance use disorder: it is higher than clinicians think it is. Eur J Psychotraumatol. 2012;3(1):17734. doi: 10.3402/ejpt.v3i0.17734.
   Google Scholar
• Gielen N, Krumeich A, Havermans RC, et al. Why clinicians do not implement integrated treatment for comorbid substance use disorder and posttraumatic stress disorder: a qualitative study. Eur J Psychotraumatol. 2014;5(1): 22821. doi: 10.3402/ejpt.v3i0.1773.
   Google Scholar
• Wynn R, Landheim A, Hoxmark E. Which factors influence psychiatric diagnosing in substance abuse treatment? Int J Ment Health Syst. 2013;7(1):17. doi: 10.1186/1752-4458-7-17.
   PubMedGoogle Scholar
• Back SE, Waldrop AE, Brady KT. Treatment challenges associated with comorbid substance use and posttraumatic stress disorder: Clinicians’ perspectives. Am J Addict. 2009;18(1):15–20. doi: 10.1080/10550490802545141.
   PubMed Web of Science ®Google Scholar
• DiClemente CC, Nidecker M, Bellack AS. Motivation and the stages of change among individuals with severe mental illness and substance abuse disorders. J Subst Abuse Treat. 2008;34(1):25–35. doi: 10.1016/j.jsat.2006.12.03410.1111/j.1465-3362.2011.00314.x.
   PubMed Web of Science ®Google Scholar
• Boden MT, Moos R. Dually diagnosed patients’ responses to substance use disorder treatment. J Subst Abuse Treat. 2009;37(4):335–345. doi: 10.1016/j.jsat.2009.03.012.
   PubMed Web of Science ®Google Scholar
• Tull MT, Gratz KL, Coffey SF, et al. Examining the interactive effect of posttraumatic stress disorder, distress tolerance, and gender on residential substance use disorder treatment retention. Psychol Addict Behav. 2013;27(3):763–773. https://psycnet.apa.org/doi/10<?sch-permit JATS-0034-007?>.1037/a0030361 doi: 10.1037/a0029911.
   PubMed Web of Science ®Google Scholar
• Westphal M, Aldao A, Jackson C. Emotion dysregulation in comorbid posttraumatic stress disorder and substance use disorders: A narrative review. Military Psychol. 2017;29(3):216–233. doi: 10.1037/mil0000157.
   Web of Science ®Google Scholar
• Glasner-Edwards S, Marinelli-Casey P, Hillhouse M, et al. Depression among methamphetamine users: association with outcomes from the methamphetamine treatment project at 3-year follow-up. J Nerv Ment Dis. 2009;197(4):225–231. doi: 10.1111/j.1465-3362.2009.00081.x.
   PubMed Web of Science ®Google Scholar
• Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, et al. Psychopathology in methamphetamine-dependent adults 3 years after treatment. Drug Alcohol Rev. 2010;29(1):12–20. doi: 10.1111/j.1465-3362.2009.00081.x.
   PubMed Web of Science ®Google Scholar
• Hasin D, Liu X, Nunes E, et al. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry. 2002;59(4):375–380. doi: 10.1001/archpsyc.59.4.375.
   PubMed Web of Science ®Google Scholar
• Samet S, Fenton MC, Nunes E, et al. Effects of independent and substance-induced major depressive disorder on remission and relapse of alcohol, cocaine and heroin dependence. Addiction. 2013;108(1):115–123. doi: 10.1111/j.1360-0443.2012.04010.x.
   PubMed Web of Science ®Google Scholar
• Ouimette P, Moos RH, Finney JW. PTSD treatment and 5-year remission among patients with substance use and posttraumatic stress disorders. J Consult Clin Psychol. 2003;71(2):410–414. doi: 10.1037/0022-006X.71.2.410.
   PubMed Web of Science ®Google Scholar
• Bentley KH, Sakurai H, Lowman KL, et al. Validation of brief screening measures for depression and anxiety in young people with substance use disorders. J Affect Disord. 2021;282:1021–1029. doi: 10.1016/j.jad.2021.01.005.
   PubMed Web of Science ®Google Scholar
• Levitt E, Syan S, Sousa S, et al. Optimizing screening for depression, anxiety disorders, and post-traumatic stress disorder in inpatient addiction treatment: A preliminary investigation. Addict Behav. 2021;112:106649. doi: 10.1016/j.addbeh.2020.106649.
   PubMed Web of Science ®Google Scholar
• Puac-Polanco V, Ziobrowski HN, Zainal NH, et al. K10 and K6 scales. In: International Handbook of Behavioral Health Assessment. Cham:Springer International Publishing; 2023. p. 1–30.
   Google Scholar
• Rush B, Castel S, Brands B, et al. Validation and comparison of diagnostic accuracy of four screening tools for mental disorders in people seeking treatment for substance use disorders. J Subst Abuse Treat. 2013;44(4):375–383. doi: 10.1016/j.jsat.2012.08.221.
   PubMed Web of Science ®Google Scholar
• Derogatis LR, Lipman RS, Rickels K, et al. The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory. Behav Sci. 1974;19(1):1–15. doi: 10.1002/bs.3830190102.
   PubMedGoogle Scholar
• Norwegian Directorate of Health. 2011). National guidelines for assessment, treatment and follow-up of people with concomitant substance use and mental illness. Oslo: Norwegian Directorate of Health. Retrieved from https://helsedirektoratet.no/Lists/Publikasjoner/Attachments/188/Nasjonal-faglig-retningslinje-personer-med-rop-lidelser-IS-1948.pdf.
   Google Scholar
• Schmalbach B, Zenger M, Tibubos AN, et al. Psychometric properties of two brief versions of the Hopkins symptom checklist: HSCL-5 and HSCL-10. Assessment. 2021;28(2):617–631. doi: 10.1177/1073191119860910.
   PubMed Web of Science ®Google Scholar
• Andersson HW, Steinsbekk A, Walderhaug E, et al. Predictors of dropout from inpatient substance use treatment: a prospective cohort study. Subst Abuse. 2018;12:1178221818760551. doi: 10.1177/1178221818760551.
   Web of Science ®Google Scholar
• Bolstad I, Lien L, Bramness JG. ADHD symptoms as risk factor for PTSD in inpatients treated for alcohol use disorder. Psychiatry Res. 2021;300:113904. 113904. doi: 10.1016/j.psychres.2021.113904.
   PubMed Web of Science ®Google Scholar
• Melby K, Gråwe RW, Aamo TO, et al. Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial. Drug Alcohol Depend. 2019;197:95–101. doi: 10.1016/j.drugalcdep.2019.01.003.
   PubMed Web of Science ®Google Scholar
• Aas CF, Vold JH, Gjestad R, et al. Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway. Subst Abuse Treat Prev Policy. 2021;16(1):20. doi: 10.1186/s13011-021-00354-1.
   PubMed Web of Science ®Google Scholar
• Andersson HW, Mosti MP, Nordfjærn T. Suicidal ideation among inpatients with substance use disorders: Prevalence, correlates and gender differences. Psychiatry Res. 2022;317:114848. doi: 10.1016/j.psychres.2022.114848.
   PubMed Web of Science ®Google Scholar
• Baumeister H, Morar V. The impact of clinical significance criteria on subthreshold depression prevalence rates. Acta Psychiatr Scand. 2008;118(6):443–450. doi: 10.1111/j.1600-0447.2008.01287.x.
   PubMed Web of Science ®Google Scholar
• Howland RH, Schettler PJ, Rapaport MH, et al. Clinical features and functioning of patients with minor depression. Psychother Psychosom. 2008;77(6):384–389. doi: 10.1159/000151519.
   PubMed Web of Science ®Google Scholar
• Goldney RD, Fisher LJ, Dal Grande E, et al. Subsyndromal depression: prevalence, use of health services and quality of life in an Australian population. Soc Psychiatry Psychiatr Epidemiol. 2004;39(4):293–298. doi: 10.1007/s00127-004-0745-5.
   PubMed Web of Science ®Google Scholar
• Haavet OR, Sirpal MK, Haugen W, et al. Diagnosis of depressed young people in primary health care - A validation of HSCL-10. Fam Pract. 2011;28(2):233–237. doi: 10.1093/fampra/cmq078.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Barragán M, Fernández-San-Martín MI, Clavería A, et al. Measuring depression in primary health care in Spain: Psychometric properties and diagnostic accuracy of HSCL-5 and HSCL-10. Front Med. 2022;9:1014340. doi: 10.3389/fmed.2022.1014340.
   Web of Science ®Google Scholar
• Lien IA, Bolstad I, Lien L, et al. Screening for depression in patients in treatment for alcohol use disorder using the Beck Depression Inventory-II and the Hopkins Symptom Checklist-10. Psychiatry Res. 2022;308:114363. doi: 10.1016/j.psychres.2021.114363.
   PubMed Web of Science ®Google Scholar
• Khan S, Okuda M, Hasin DS, et al. Gender differences in lifetime alcohol dependence: Results from the national epidemiologic survey on alcohol and related conditions. Alcohol Clin Exp Res. 2013;37(10):1696–1705. doi: 10.1111/acer.12158.
   PubMed Web of Science ®Google Scholar
• Kilpatrick DG, Resnick HS, Milanak ME, et al. National estimates of exposure to traumatic events and PTSD prevalence using DSM-IV and DSM-5 criteria. J Trauma Stress. 2013;26(5):537–547. doi: 10.1002/jts.21848.
   PubMed Web of Science ®Google Scholar
• McHugh RK, Sugarman DE, Meyer L, et al. The relationship between perceived stress and depression in substance use disorder treatment. Drug Alcohol Depend. 2020;207:107819. doi: 10.1016/j.drugalcdep.2019.107819.
   PubMed Web of Science ®Google Scholar
• Silove D, Baker JR, Mohsin M, et al. The contribution of gender-based violence and network trauma to gender differences in post-traumatic stress disorder. PLOS One. 2017;12(2):e0171879. doi: 10.1371/journal.pone.0171879.
   PubMed Web of Science ®Google Scholar
• Bizzarri JV, Rucci P, Sbrana A, et al. Substance use in severe mental illness: self-medication and vulnerability factors. Psychiatry Res. 2009;165(1–2):88–95. doi: 10.1016/j.psychres.2007.10.009.
   PubMed Web of Science ®Google Scholar
• Drapkin ML, Yusko D, Yasinski C, et al. Baseline functioning among individuals with posttraumatic stress disorder and alcohol dependence. J Subst Abuse Treat. 2011;41(2):186–192. doi: 10.1016/j.jsat.2011.02.012.
   PubMed Web of Science ®Google Scholar
• Straus E, Haller M, Lyons RC, et al. Functional and psychiatric correlates of comorbid post-traumatic stress disorder and alcohol use disorder. Alcohol Res: Curr Rev. 2018;39(2):121.
   Web of Science ®Google Scholar
• Mills KL, Teesson M, Ross J, et al. Trauma, PTSD, and substance use disorders: Findings from the Australian national survey of mental health and well-being. Am J Psychiatry. 2006;163(4):652–658. doi: 10.1176/ajp.2006.163.4.652.
   PubMed Web of Science ®Google Scholar
• Reynolds M, Mezey G, Chapman M, et al. Co-morbid post-traumatic stress disorder in a substance misusing clinical population. Drug Alcohol Depend. 2005;77(3):251–258. doi: 10.1016/j.drugalcdep.2004.08.017.
   PubMed Web of Science ®Google Scholar
• WHO. Declaration of Helsinki: World Medical Association Declaration of Helsinki. Bull World Health Organization. 2001;79:373–374.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger Met al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLOS Med. 2007;4(10):e296. doi: 10.1371/journal.pmed.0040296
   PubMed Web of Science ®Google Scholar
• Strand BH, Dalgard OS, Tambs K, et al. Measuring the mental health status of the Norwegian population: a comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36). Nord J Psychiatry. 2003;57(2):113–118. doi: 10.1080/08039480310000932.
   PubMed Web of Science ®Google Scholar
• Sandanger I, Moum T, Ingebrigtsen G, et al. Concordance between symptom screening and diagnostic procedure: the Hopkins Symptom Checklist-25 and the Composite International Diagnostic Interview I. Soc Psychiatry Psychiatr Epidemiol. 1998;33(7):345–354. doi: 10.1007/s001270050064.
   PubMed Web of Science ®Google Scholar
• WHO. 1992). The ICD10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines. http://apps.who.int/iris/handle/10665/37958.
   Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20(20):22–33.
   PubMedGoogle Scholar
• Xia J, Broadhurst DI, Wilson M, et al. Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics. 2013;9(2):280–299. doi: 10.1007/s11306-012-0482-9.
   PubMed Web of Science ®Google Scholar
• Alonso J, Angermeyer MC, Bernert S, et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand. 2004;109(s420):5–7. doi: 10.1111/j.1600-0047.2004.00327.x.
   Web of Science ®Google Scholar
• Andersson HW, Lilleeng SE, Ruud T, et al. Substance use among patients in specialized mental health services in Norway: prevalence and patient characteristics based on a national census. Nord J Psychiatry. 2020;75(3):160–169. doi: 10.1080/08039488.2020.1817553.
   PubMed Web of Science ®Google Scholar
• McHugh RK. Treatment of co-occurring anxiety disorders and substance use disorders. Harv Rev Psychiatry. 2015;23(2):99–111. doi: 10.1097/HRP.0000000000000058.
   PubMed Web of Science ®Google Scholar
• Torrens M, Gilchrist G, Domingo-Salvany A,. Psychiatric comorbidity in illicit drug users: substance-induced versus independent disorders. Drug Alcohol Depend. 2011;113(2-3):147–156. doi: 10.1016/j.drugalcdep.2010.07.013.
   PubMed Web of Science ®Google Scholar
• Dore G, Mills K, Murray R, et al. Post-traumatic stress disorder, depression and suicidality in inpatients with substance use disorders. Drug Alcohol Rev. 2012;31(3):294–302. doi: 10.1111/j.1465-3362.2011.00314.x.
   PubMed Web of Science ®Google Scholar
• Hassan AN, Le Foll B. Polydrug use disorders in individuals with opioid use disorder. Drug Alcohol Depend. 2019;198:28–33. doi: 10.1016/j.drugalcdep.2019.01.031.
   PubMed Web of Science ®Google Scholar
• Swendsen J, Conway KP, Degenhardt L, et al. Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction. 2010;105(6):1117–1128. doi: 10.1111/j.1360-0443.2010.02902.x.
   PubMed Web of Science ®Google Scholar
• Zhang S, Lin X, Liu J, et al. Prevalence of childhood trauma measured by the short form of the Childhood Trauma Questionnaire in people with substance use disorder: A meta-analysis. Psychiatry Res. 2020;294:113524. doi: 10.1016/j.psychres.2020.11352410.1186/s13011-021-00354-1.
   PubMed Web of Science ®Google Scholar
• Kingston RE, Marel C, Mills KL. A systematic review of the prevalence of comorbid mental health disorders in people presenting for substance use treatment in Australia. Drug Alcohol Rev. 2017;36(4):527–539. doi: 10.1111/dar.12448.
   PubMed Web of Science ®Google Scholar